Investor Presentation

January 2019

CSE ticker: GW

VALENS GROWORKS

DISCLAIMER

This Presentation contains forward-looking statements and forward-looking information. Often, but not always, forward-looking statements can be identified by the use of words or phrases or state that certain actions,

events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown words such as “plans”, “expects” or “does not expect”, “is expected”,

“estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and risks, uncertainties and other factors which may cause the actual results, performance or achievements of the

Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements and information. Examples of such statements include: (A) the financial

forecast of the Company; (B) the intention to grow the business and operations of the Company; (C) anticipated timing for the availability of the Company’s products to market and expected sale prices; (D) expected

growth in the number of users of medical and recreational marijuana anticipated; and (E) the expansion of the Company’s business into other revenue streams. Actual results and developments are likely to differ, and may

differ materially, from those expressed or implied by the forward-looking statements contained in this Presentation. Such forward-looking statements are based on a number of assumptions which may prove to be

incorrect, including, but not limited to: the ability of the Company to obtain necessary financing; the ability to complete a going public transaction; the ability to satisfy the requirements of a stock exchange; the economy

generally; consumer interest in the products of the Company; competition; and anticipated and unanticipated costs. These forward-looking statements should not be relied upon as representing the Company’s views as of

any date subsequent to the date of this Presentation. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in

forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be

accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking

statements and information contained in this Presentation are expressly qualified in their entirety by this cautionary statement. The forward-looking statements and information included in this Presentation are made as

of the date of this Presentation and the Company assumes no obligation to update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities

legislation.

NOTICE TO RECIPIENT

This investment is suitable only for sophisticated investors for whom an investment does not constitute a complete investment program, who do not require immediate liquidity for their investment and who fully

understand and are willing to assume the risks involved. An investment may be considered to involve a substantial degree of risk, and an investor could lose all or a substantial amount of his or her investment. This

document is not an offer to sell (or solicitation of an offer to buy) any interest in the Company. These materials may not be used or relied upon for any purpose other than as specifically contemplated by a written

agreement. The materials may not be circulated outside of the recipient’s organization, publicly referred to, or disclosed, in whole or in part, without express written permission. This presentation does not purport to be all

inclusive or contain all the information that a prospective investor may require to fully evaluate an investment in the contemplated transaction. Prospective investors should conduct their own thorough investigation and

due diligence before making an investment.

2

CSE ticker: VGW

VALENS GROWORKS

One of the largest premium cannabis extraction companies in North America

and the first colab facilitating cannabis product development for licensed producers globally

3

VALENS GROWORKS 4THE VALENS ADVANTAGE

THE WORLD IS OUR MARKET

Health Canada licensed (multiple), EU GMP certification

pending, Hemp License pending, Nutraceutical License

pending –setting Valens up for every servicing and

consumer product opportunity, globally.

DEVELOPMENT

Through one of our Dealer’s

Licenses we hold the ability to

perform research and clinical trials

to better understand Cannabis and

it’s benefits, and to lead the way in

purposeful product offerings

around the world.

BIG PICTURE BRANDING

The Valens brand is recognized for

delivering the most science driven,

responsibly tested, sustainably derived

products and services in the market.

INDUSTRY-BACKED

The experience and reputation of the

team at Valens speaks for itself. We are a

preferred partner of Canopy and other

reputable industry players.

PRODUCT FLEXIBILITY

We have the ability to produce a wide variety of

products, allowing Valens to capitalize on

multiple markets from medical to recreational to

preferential method of consumption.

SEED TO SALE TRANSPARENCY AND CONTROL

Different strains, compounds and growing techniques

provide different desired effects in finished products.

By controlling our supply from the source right through

to processing, we’re able to ensure our products

qualities are maximized and always purpose-driven.

PROPRIETARY PROCESSING

Our processing methods have been customized

to ensure that the end product does not lose the

valuable complexity of compounds responsible

for the spectrum of desired effects that are often

lost in the refining process.

VALENS GROWORKS

Health Canada licensed cannabis extraction center

• Extraction center with cultivation and research capabilities

• Proprietary, customized cannabis extraction processes

• Ability to import and export wholesale cannabis products

world-wide

• Third party cannabis product development

• One of the largest capacities to extract in Canada and growing

• 25,000 sq ft plant to facilitate additional extraction production

• EU GMP Certification pending for global export anywhere

VALENS AGRITECH LTD.

VALENS GROWORKSVALENS LABS LTD.Health Canada licensed cannabis extraction center

• Health Canada Dealers Licensed for testing and analysis

• Leading edge research laboratory

• Service provider specializing in the testing of metals, residual solvents,

pesticides, mold, terpenes and cannabinoid profile

• ISO 17025 accreditation, first lab to be accredited in Canada for a

cannabis matrix

• Named a “Center of Excellence in Plant Based Science” by $115B

medical instruments company Thermo Fischer Scientific

• Setting the domestic standard in Health Canada-required third party

product verification as well as globally.

VALENS GROWORKSVALENS REVENUE STREAMS

EXTRACTION

RESIN REFINED OILProcessing from

flower to crude oil

Processing from flower to

oil ready for marketProcessing and packaging

of oil for market

Fee for service Fee for service

or

Revenue shareRevenue share

OTHER REVENUE SOURCES

• Lab Testing Services

• Direct Sales

• Export Sales

• 3rd Party Research &

Development

• Product Development

ABILITY TO CREATE

CUSTOM, FLEXIBLE

AGREEMENTS

WHITE LABEL

PRODUCTS

7

VALENS GROWORKS

EDIBLES

• Snack edibles – Trail mix, protein bars, jerky, sweets,

etc.

• Infused prepared meals

• Food additives – Cooking oils, honey, peanut butter

• “Just add cannabis” – beverage containers with

cannabis oil preloaded in the top, just like the

vitamin waters

• with the powder dispenser on top

• Drinks – alcoholic or non-alcoholic

• Oral sprays

OIL/TINCTURES

• High THC/CBD tinctures

• Vaporizer Cartridges and Pens

• Capsules

• Concentrates

TOPICALS

• Balms/creams/salves

• Bath soaks/salts

• Skin care products

• Body sprays

• Lubricants

• Essential oils

• Sublingual patches

• Transdermal patches

EXTRACTION: THE FOUNDATION OF OPPORTUNITY 8

VALENS GROWORKS

SōRSE emulsion technology surrounds oils, transforming the entire solution into water-compatible forms

All of this means you can add cannabis to products including beverages without that "weed" taste or smell.

BREAKTHROUGH ITEMS TO NOTE

• Shelf stable for over 180 days (not proven anywhere else)

• Zero cannabis taste, color or odor

• Provides effective, consistent dosing

• Lower dosage sufficient due to increase in bioavailability when consumed

• Faster onset and offset, making it the safer and more trusted edible option

WHAT THIS MEANS FOR VALENS

• Value-add in our oil services process to provide clients with water-soluble cannabis ready for mixing in

liquids by the client

• Powder product ready to go to market that consumers can mix with any liquid of their own

• Exclusive Canadian rights to all Tarukino beverages including the #1 selling cannabis beverage in

Washington, three years in a row, Happy Apple Cider.

SoRSE TECHNOLOGY 9

VALENS GROWORKS

INTERNATIONAL OPPORTUNITIES

C A N A D A - R x 2 0 0 1

R e c r e a t i o n a l 2 0 1 8

C O L O M B I A - R x 2 0 1 7

B R A Z I L - R x 2 0 1 6

P E R U - R x 2 0 1 7

G E R M A N Y - R x 2 0 1 7

M A L T A - R x 2 0 1 8

A U S T R A L I A - R x 2 0 1 7

N E W Z E A L A N D - R x 2 0 1 7

J A M A I C A - R x 2 0 1 7

10

A C T I V E L Y P U R S U I N G I N T E R N A T I O N A L L I C E N S I N G & D I S T R I B U T I O N

GLOBAL LEGAL MARIJUANA

MARKET EXPECTED TO REACH

146.4 BILLION USD

BY 2025-REPORT BUYER, APRIL 2018

GLOBAL

MARKET

EUROPEAN MEDICAL AND

RECRECATIONAL MARKETS

EXPECTED TO GROW TO €116.4

BILLION BY 2028- THE EUROPEAN CANNABIS REPORT,

PROHIBITION PARTNERS

AS OF JUNE 7, 2018, CANADA IS

THE FIRST MEMBER OF THE G7 TO

LEGALIZE CANNABIS FOR

RECREATIONAL USE ACROSS THE

COUNTRY

C U R R E N T N E G O T I A T I O N S F O R

CSE ticker: VGW

VALENS GROWORKS

STRATEGICPARTNERSHIPS

C H A P T E R T W O

11

VALENS GROWORKS

INITIATING COVERAGE Altacorp Capital

VALENS GROWORKS

TYLER ROBSON

CEO / DIRECTOR

With 15+ years grassroots experience, Mr.

Robson was Chief Operating Officer of the

Company until taking the reins as Chief

Executive Officer in May 2017, as well as

remaining Director of Operations at Valens

AgriTech Inc.

SCOTT YOUNG

IR& BUSINESS DEVELOPMENT

Mr. Young’s focus at Valens is corporate

finance initiatives. Mr. Young has spent the

past 15 years working in the capital market

sectors of Canada, the United States and

Europe.

CHRIS BUYSEN,

MPAcc, CPA, CA

CFO

Mr. Buysen has over 15 years of diverse

financial experience working as a senior

financial executive with many public and

private organizations in a wide range of

industries including retail, pharmacy and

consumer packaged goods.

CHANTEL POPOFF

VP

In 2007, Ms. Popoff was appointed Director

of Operations, then Director of Marketing for

a fast-growing Western Canadian retail

pharmacy chain. In 2013 she joined a natural

health food company as Director of

Marketing and was promoted to President in

2016.

EVERETT KNIGHT, CFA

EVP OF STRATEGY/INVESTMENTS

Mr. Knight has managed one of the only

institutional investment mandates focused

on the cannabis industry where he analyzed

and toured hundreds of cannabis companies.

His experience in the sector began in 2014

and since that time, has accumulated a

thorough understanding of the industry,

regulations, subsectors and the companies

involved in this fast growing space.

MANAGEMENT

QUINN SHISKIN

HEAD OF PRODUCTION

Mr. Shiskin’s career emanates around

production as a multi-ticketed Red Seal

tradesman; where he worked in a variety of

industries including mining, oil sands, LNG,

pulp and paper, and in the construction

industry. With these skills, he entered the

extraction industry where he revolutionized

the process along the way.

13

VALENS GROWORKS

L O C A T I O N

2 3 0 C A R I O N R D .

K E L O W N A , B R I T I S H C O L U M B I A

C A N A D A V 4 V 2 K 5

C O N T A C T U S

E V E R E T T @ V A L E N S G R O W O R K S . C O M

( 7 7 8 ) - 7 5 5 - 0 0 5 2

S C O T T @ V A L E N S G R O W O R K S . C O M

( 7 0 5 ) 8 8 8 - 2 7 5 6

14

W W W . V A L E N S G R O W O R K S . C O M